CASP3 and gastric cancer: The present work demonstrates that GANT61 decreases ES cell viability, mainly through a caspase-3/7/PARP-dependent cell apoptosis pathway, and in accordance with previous studies conducted in neuroblastoma, squamous lung cancer or gastric cancer cells [45,46,47].